Form EFFECT PLUS THERAPEUTICS, INC.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 5, 2026 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CNSide Diagnostics receives CAP laboratory accreditation
- LYSOL® DECLARES JULY 5TH "ADDRESS THE MESS" DAY, AS TWO-THIRDS OF U.S. ADULTS SAY THEY LOSE TIME TO CLEANING DURING CELEBRATIONS
- Goodwater Capital Releases 2026 U.S. Consumer Survey That Tracks AI’s Growing Role in Everyday Life
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share